Skip to main content
. 2017 Oct 30;15(1):473–478. doi: 10.3892/etm.2017.5401

Figure 1.

Figure 1.

Expression of TPD52L2 (A) mRNA and (B) protein in prostate cancer tissues and tumor-adjacent normal tissues. Reverse transcription-quantitative polymerase chain reaction was used to determine the expression of TPD52L2 mRNA and western blot analysis was used to measure TPD52L2 protein expression. *P<0.05 and **P<0.01 vs. control. TPD52L2, tumor protein D52 like 2.